Pharma Equity Correlations
| PEG Stock | 0.50 0.16 6.67% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Pharma Equity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Pharma Equity Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Pharma |
The ability to find closely correlated positions to Pharma Equity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Pharma Equity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Pharma Equity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Pharma Equity Group to buy it.
Moving together with Pharma Stock
| 0.78 | NOVO-B | Novo Nordisk AS | PairCorr |
| 0.66 | ORSTED | Orsted AS | PairCorr |
| 0.86 | VWS | Vestas Wind Systems | PairCorr |
| 0.74 | GMAB | Genmab AS | PairCorr |
| 0.71 | CARL-B | Carlsberg AS | PairCorr |
Moving against Pharma Stock
| 0.7 | MAERSK-B | AP Mller | PairCorr |
| 0.69 | MAERSK-A | AP Mller | PairCorr |
| 0.61 | DSV | DSV Panalpina AS | PairCorr |
| 0.43 | NDA-DK | Nordea Bank Abp | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Pharma Stock performing well and Pharma Equity Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pharma Equity's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BAIKLA | 1.02 | 0.08 | (0.03) | (1.12) | 1.59 | 2.13 | 8.77 | |||
| NORD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| KRE | 0.79 | 0.02 | (0.09) | (0.01) | 0.97 | 1.41 | 4.35 | |||
| LOLB | 1.05 | (0.06) | 0.00 | 0.41 | 0.00 | 2.68 | 7.18 | |||
| SYDB | 1.01 | 0.04 | (0.07) | (6.84) | 1.31 | 1.81 | 6.18 | |||
| CMINOA | 0.77 | (0.17) | 0.00 | (0.16) | 0.00 | 1.69 | 3.61 | |||
| SMSMED | 1.98 | (0.09) | 0.00 | 0.84 | 0.00 | 4.08 | 14.81 |
Pharma Equity Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pharma Equity stock to make a market-neutral strategy. Peer analysis of Pharma Equity could also be used in its relative valuation, which is a method of valuing Pharma Equity by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |